Lung Cancer Treatmentin / Top clinic in Germany, Friedrichshafen

Lung Cancer Treatmentin Germany

Treatment of lung cancer in Germany means having high level medical care with use the latest diagnostics and therapy methods developed according to the modern scientific standards.

Lung cancer (or bronchial carcinoma, bronchogenic cancer) is one of the most common type of cancers.

Risks Factors

  • Smoking: The most important etiologic risk factor for bronchial carcinoma is certainly active smoking. According to the World Health Organization statistics, in 90% of men and 60% of women, bronchial carcinomas were caused by smoking.
  • The increased concentration of radon and its decay products in the inhaled air
  • Professions associated with systemic exposure to carcinogens
  • Environmental pollution, adverse environmental conditions
  • Genetic factor

Diagnostics

When bronchogenic carcinoma is suspected, first, imaging diagnostic procedures such as X-ray or computer tomography are performed, which especially required when the patient suffering of symptoms such as cough, hemoptysis, labored breathing, increased body temperature, and weight loss. In addition, in cases of suspected bronchial carcinoma bronchoscopy as a diagnostic method can be used.

In order to perform more advanced diagnostics and determine further treatment strategy, the German clinics specialists resort to the following methods:

  • Computed tomography of the chest in Germany
  • CT scan or MRI of the brain in Germany
  • Ultrasound (sonography) in Germany
  • Skeletal scintigraphy in Germany
  • Bone marrow biopsy Germany

Of course, a tumor does not occur suddenly, cancer penetrating into tissues is a long-term process. However, recognizing the tumor is very difficult in the early stages, since it practically does not cause symptoms. The lung cancer tumor less than one centimeter often is simply not noticed on the X-ray images, as it can be identified only by very experienced radiologist. Treatment of lung cancer in most cases begins when the patient is already at an advanced stage of the disease, so all the patients with high risk of bronchial carcinoma are recommended to see the doctor regularly for early detection of cancer.

Types of Lung Cancer. Methods of treatment in Germany

Treatment of bronchial carcinoma is of various kinds, depending on the type of tumor. There are small cell lung carcinoma and non-small cell lung carcinoma.

Non-small cell bronchial carcinoma is a collective term covering several different forms of lung cancer, which are characterized by a relatively slow development and are located in limited areas of the lung.

Treatment of lung cancer with non-small cell carcinoma has a more optimistic outlook. On the other hand, non-small cell carcinoma is less sensitive to chemotherapy that reduces a range of treatment methods. Treatment for lung cancer depends on the stage of the disease. Since therapeutic measures influences lung function, the general condition and age of the patient at the same time play a role. The surgery can guarantee the successful treatment of bronchial carcinoma in the early stages.

Treatment of lung cancer at later stages, in most cases, is carried out with chemotherapy and radiotherapy, but surgery also can be performed in some cases. The goal of surgery for the treatment of lung cancer is complete removal of the tumor and nearby metastatic lymph nodes. Radiation therapy in combination with nuclear therapy is usually applied for treatment of patients on advanced stages and those who have inoperable bronchial carcinoma.

Small cell carcinoma is less common, but more aggressive kind of malignant lung tumor. The majority of patients diagnosed with the last one usually have metastases in other organs. Meanwhile, small cell bronchial carcinoma is particularly "sensitive" to chemotherapy and radiation, so, when choosing a treatment, that two ways of therapy are preferable.

Survival Prognosis in Bronchial Carcinoma (Lung Cancer)

Distant prognosis of bronchogenic cancer generally is quite unfavorable. Life expectancy of patients with lung carcinoma depends on many factors:

  • cancer type (small cell or non-small cell bronchial carcinoma);
  • cancer stage;
  • location of the tumor;
  • general physical condition of the patient;
  • sex and age of the patient.

Revealing of bronchial carcinoma in early stages significantly increases the probability of survival and the patient's chances of a complete cure of malignant disease. In earlier stages, about 40-50% of patients survive for 5 years or more. When bronchial carcinoma had found in the later stages, the survival rate and life expectancy of patients significantly reduced.

The lowest survival rates observed in patients with small cell bronchial carcinoma, their average life expectancy is about 8-12 months. However, patients still have a chance to cure the disease as, at least 5% of all the tumors, disappear after chemotherapy or radiation.

Patients who had lung cancer are recommended to undergo regular medical examinations in order to prevent a recurrence or reveal the recurrent disease in early stage. In addition to such methods of diagnostics as a physical examination and a blood test, X-rays, bronchoscopy, ultrasound and computed tomography play a huge role in the identification of secondary tumor.

Rehabilitation in Germany

The clinics of Germany provide to the patients with lung cancer (bronchial carcinoma) a unique opportunity of a full post-operative rehabilitation in order to ensure proper recovery after surgery. The main goal of rehabilitation in Germany is to improve the quality of life of the patient and return them to professional activity.

Lung Cancer Treatmentin

4.0/5 (13 votes)

Comments and questions

 

Write down your comments or questions in this application form!

 

Your name: *
Your Email:
Comment: *

Department

Facts and Figures

  • 30 rectum resections with da Vinci® robot
  • 207 inguinal hernia surgeries
  • 725 veins and arteries surgeries
  • 250 intestine surgeries
  • 423 stomach surgeries
  • 70% of all surgeries are minimally invasive
Services

General Surgery

Veins

Medical Staff

MD PV Thorsten Lehmann

MD PV Thorsten Lehmann
Head of the Surgery Department

MD Jürgen Kies

MD Jürgen Kies
Senior physician

MD Frank Aspacher

MD Frank Aspacher
Senior physician

MD Stefan Tange

MD Stefan Tange
Senior physician

B. Schmollinger

B. Schmollinger
Medical secretary

DO YOU HAVE QUESTIONS? CALL NOW!
+49 7541 97 82 751

OR WRITE TO US:

Callback Service